Sensitization of gram-negative bacteria by targeting the membrane potential

FASEB Journal

Volumn 27, Issue 9, 2013, Pages 3818-3826

  Goldberg, Keren ^a   Sarig, Hadar ^a   Zaknoon, Fadia ^a   Epand, Raquel F ^b   Epand, Richard M ^b   Mor, Amram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Host defense peptides; Oligoacyl lysyl; Peptidomimetics; Proton motive force; Synergy

Indexed keywords

AMIDE; DODECENOYL LYSYL [LYSYL AMINODODECANOYLCLYSYL] AMIDE; ERYTHROMYCIN; OXACILLIN; PENICILLIN G; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHEMOSENSITIZATION; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

HOST DEFENSE PEPTIDES; OLIGO-ACYL-LYSYL; PEPTIDOMIMETICS; PROTON MOTIVE FORCE; SYNERGY;

ANIMALS; ANTI-BACTERIAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; GRAM-NEGATIVE BACTERIA; LIPOPEPTIDES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMBRANE POTENTIALS; MICE; MICROBIAL SENSITIVITY TESTS; PEPTIDOMIMETICS; PROTON-MOTIVE FORCE; SURFACE PLASMON RESONANCE; THIGH;

EID: 84883311713     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-227942     Document Type: Article

References (52)

1. Aminov, R. I. (2010) A brief history of the antibiotic era: lessons learned and challenges for the future. Front. Microbiol. 1, 134
2. Butler, M. S., and Cooper, M. A. (2011) Antibiotics in the clinical pipeline in 2011. J. Antibiot. (Tokyo) 64, 413-425
3. Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., and Edwards, J. E., Jr. (2004) Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38, 1279-1286
4. Torres, J. A., Villegas, M. V., and Quinn, J. P. (2007) Current concepts in antibiotic-resistant gram-negative bacteria. Expert Rev. Anti. Infect. Ther. 5, 833-843
5. Higgins, C. F. (2007) Multiple molecular mechanisms for multidrug resistance transporters. Nature 446, 749-757
6. Nikaido, H. (2009) Multidrug resistance in bacteria. Annu. Rev. Biochem. 78, 119-146
7. Paulsen, I. T., Brown, M. H., and Skurray, R. A. (1996) Protondependent multidrug efflux systems. Microbiol. Rev. 60, 575-608
8. Aires, J. R., and Nikaido, H. (2005) Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J. Bacteriol. 187, 1923- 1929
9. Martinac, B., Saimi, Y., and Kung, C. (2008) Ion channels in microbes. Physiol. Rev. 88, 1449-1490
10. Strahl, H., and Hamoen, L. W. (2010) Membrane potential is important for bacterial cell division. Proc. Natl. Acad. Sci. U. S. A. 107, 12281-12286
11. Wu, M., Maier, E., Benz, R., and Hancock, R. E. (1999) Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38, 7235-7242
12. Koo, S. P., Yeaman, M. R., Nast, C. C., and Bayer, A. S. (1997) The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein. Infect. Immun. 65, 4795-4800
13. Westerhoff, H. V., Juretic, D., Hendler, R. W., and Zasloff, M. (1989) Magainins and the disruption of membrane-linked freeenergy transduction. Proc. Natl. Acad. Sci. U. S. A. 86, 6597-6601
14. Hancock, R. E., and Sahl, H. G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24, 1551-1557
15. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389-395
16. Sakoulas, G., Bayer, A. S,, Pogliano, J., Tsuji, B. T., Yang, S. J., Mishra, N. N., Nizet, V., Yeaman, M. R., and Moise, P. A. (2012) Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 56, 838-844
17. Daugelavicius, R., Bakiene, E., and Bamford, D. H. (2000) Stages of polymyxin B interaction with the Escherichia coli cell envelope. Antimicrob. Agents Chemother. 44, 2969-2978
18. Silverman, J. A., Perlmutter, N. G., and Shapiro, H. M. (2003) Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47, 2538-2544
19. Choi, S., Isaacs, A., Clements, D., Liu, D., Kim, H., Scott, R. W., Winkler, J. D., and DeGrado, W. F. (2009) De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc. Natl. Acad. Sci. U. S. A. 106, 6968- 6973
20. Epand, R. F., Pollard, J. E., Wright, J. O., Savage, P. B., and Epand, R. M. (2010) Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins. Antimicrob. Agents Chemother. 54, 3708-3713
21. Epand, R. M., Rotem, S., Mor, A., Berno, B., and Epand, R. F. (2008) Bacterial membranes as predictors of antimicrobial potency. J. Am. Chem. Soc. 130, 14346-14352
22. Livne, L., Kovachi, T., Sarig, H., Epand, R. F., Zaknoon, F., Epand, R. M., and Mor, A. (2009) Design and characterization of a broad -spectrum bactericidal acyl-lysyl oligomer. Chem. Biol. 16, 1250-1258
23. Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., and Mor, A. (2007) Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol. 25, 657-659
24. Radzishevsky, I. S., Kovachi, T., Porat, Y., Ziserman, L., Zaknoon, F., Danino, D., and Mor, A. (2008) Structure-activity relationships of antibacterial acyl-lysine oligomers. Chem. Biol. 15, 354- 362
25. Epand, R. F., Mor, A., and Epand, R. M. (2011) Lipid complexes with cationic peptides and OAKs; their role in antimicrobial action and in the delivery of antimicrobial agents. Cell. Mol. Life Sci. 68, 2177-2188
26. Livne, L., Epand, R. F., Papahadjopoulos-Sternberg, B., Epand, R. M., and Mor, A. (2010) OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria. FASEB J. 24, 5092-5101
27. Sarig, H., Livne L, Held-Kuznetsov, V., Zaknoon, F., Ivankin, A., Gidalevitz, D., and Mor, A. (2010) A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J. 24, 1904-1913
28. Epand, R. F., Sarig, H., Mor, A., and Epand, R. M. (2009) Cell-wall interactions and the selective bacteriostatic activity of a miniature oligo-acyl-lysyl. Biophys. J. 97, 2250-2257
29. Sarig, H., Goldfeder, Y., Rotem, S., and Mor, A. (2011) Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-acyl-lysyl. Antimicrob. Agents Chemother. 55, 688-695
30. Zhang, L., Dhillon, P., Yan, H., Farmer, S., and Hancock, R. E. (2000) Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44, 3317-3321
31. Lehrer, R. I., Barton, A., and Ganz, T. (1988) Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry. J. Immunol. Methods 108, 153-158
32. Gaidukov, L., Fish, A., and Mor, A. (2003) Analysis of membrane- binding properties of dermaseptin analogues: relationships between binding and cytotoxicity. Biochemistry 42, 12866- 12874
33. Sarig, H., Ohana, D., Epand, R. F., Mor, A., and Epand, R. M. (2011) Functional studies of cochleate assemblies of an oligoacyl- lysyl with lipid mixtures for combating bacterial multidrug resistance. FASEB J. 25, 3336-3343
34. Qian, C. D., Wu, X. C., Teng, Y., Zhao, W. P., Li, O., Fang, S. G., Huang, Z. H., and Gao, H. C. (2012) Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria. Antimicrob. Agents Chemother. 56, 1458-1465
35. Epand, R. M., and Epand, R. F. (2011) Bacterial membrane lipids in the action of antimicrobial agents. J. Peptide Sci. 17, 298-305
36. Rotem, S., Radzishevsky, I. S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., and Mor, A. (2008) Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J. 22, 2652-2661
37. Shafer, W. M., Qu, X., Waring, A. J., and Lehrer, R. I. (1998) Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/ nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U. S. A. 95, 1829-1833
38. Seeger, M. A., Diederichs, K., Eicher, T., Brandstätter, L., Schiefner, A., Verrey, F., and Pos, K. M. (2008) The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance. Curr. Drug Targets 9, 729-749
39. Rieg, S., Huth, A., Kalbacher, H., and Kern, W. V. (2009) Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Int. J. Antimicrob. Agents 33, 174-176
40. Schumacher, A., Trittler, R., Bohnert, J. A., Kümmerer, K., Pagès, J. M., and Kern, W. V. (2007) Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. J. Antimicrob. Chemother. 59, 1261-1264
41. Zgurskaya, H. I., and Nikaido, H. (1999) Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 96, 7190-7195
42. Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., and Wright, G. D. (2011) Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 7, 348-350
43. Viveiros, M., Martins, A., Paixão, L., Rodrigues, L., Martins, M., Couto, I., Fähnrich, E., Kern, W. V., and Amaral, L. (2008) Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int. J. Antimicrob. Agents 31, 458-462
44. Bolintineanu, D., Hazrati, E., Davis, H. T., Lehrer, R. I., and Kaznessis, Y. N. (2010) Antimicrobial mechanism of poreforming protegrin peptides: 100 pores to kill E. coli. Peptides 31, 1-8
45. Acar, J. F. (2000) Antibiotic synergy and antagonism. Med. Clin. North Am. 84, 1391-1406
46. Mangoni, M. L., Epand, R. F., Rosenfeld, Y., Peleg, A., Barra, D., Epand, R. M., and Shai, Y. (2008) Lipopolysaccharide, a key molecule involved in the synergism between temporins in inhibiting bacterial growth and in endotoxin neutralization. J. Biol. Chem. 283, 22907-22917
47. Steenbergen, J. N., Mohr, J. F., and Thorne, G. M. (2009) Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. J. Antimicrob. Chemother. 64, 1130-1138
48. Ulvatne, H., Karoliussen, S., Stiberg, T., Rekdal, O., and Svendsen, J. S. (2001) Short antibacterial peptides and erythromycin act synergically against Escherichia coli. J. Antimicrob. Chemother. 48, 203-208
49. Vaara, M., Fox, J., Loidl, G., Siikanen, O., Apajalahti, J., Hansen, F., Frimodt-Møller, N., Nagai, J., Takano, M., and Vaara, T. (2008) Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents. Antimicrob. Agents Chemother. 52, 3229-3236
50. Hancock, R. E. (1984) Alterations in outer membrane permeability. Annu. Rev. Microbiol. 38, 237-264
51. Vaara, M., and Vaara, T. (1983) Sensitization of gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature 303, 526-528
52. Schiffelers, R. M., Storm, G., ten Kate, M. T., Stearne-Cullen, L. E., den Hollander, J. G., Verbrugh, H. A., and Bakker-Woudenberg, I. A. (2001) In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime. J. Pharmacol. Exp. Ther. 298, 369-375